Home/Armas Pharmaceuticals/Joe Niemi

JN

Joe Niemi

President & CEO

Armas Pharmaceuticals

Therapeutic Areas

Oncology Anesthesia Infectious Disease Cardiovascular Nutritional Deficiency

Armas Pharmaceuticals Pipeline

Drug	Indication	Phase
Lidocaine Jelly 2%	Local Anesthesia	ANDA Approved
Portfolio from Steriscience Partnership	Various	ANDA Development/Filing

Leadership Team at Armas Pharmaceuticals

Executive Chairman and Founder

View full Armas Pharmaceuticals profile